Roivant

Roivant is a biopharmaceutical company focused on accelerating the development and commercialization of innovative medicines. Founded in 2014, the company builds agile, focused subsidiaries known as “Vants,” each organized around particular therapeutic programs or technologies, while providing them with shared expertise, capital, and infrastructure from the broader Roivant platform.

Roivant and its Vants develop therapies across areas including autoimmune, inflammatory, and pulmonary diseases, using a model designed to combine the focus of a biotechnology startup with the resources of a larger organization. Beyond therapeutics, Roivant also incubates discovery-stage biotechnology and health technology companies and applies technology across drug discovery, clinical development, and commercialization.